Quarterly report pursuant to Section 13 or 15(d)

Description of Business and Summary of Significant Accounting Policies (Tables)

v3.23.3
Description of Business and Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2023
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash The following is a summary of cash, cash equivalents and restricted cash at September 30, 2023 and December 31, 2022:
(in thousands)   September 30,
2023		     December 31,
2022		  
Cash and cash equivalents   $ 82,978     $ 108,910  
Restricted cash - current    
-
       396  
Restricted cash – long-term     310       302  
Cash, cash equivalents and restricted cash   $ 83,288     $ 109,608  
Schedule of Diluted Net Loss Per Share Anti-Dilutive the Company’s potentially dilutive shares, which include outstanding common stock options, restricted stock units and warrants, have not been included in the computation of diluted net loss per share as the result would have been anti-dilutive.
(in thousands)   September 30,
2023		     September 30,
2022		  
Stock Options     3,304       3,192  
Restricted Stock Units     305       300  
Warrants     1,442       1,443  
Total     5,051       4,935